1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New Jersey >
  6. RK Pharma Acquires Vgyaan Pharmaceuticals

M&A Deal Summary

RK Pharma Acquires Vgyaan Pharmaceuticals

On June 15, 2023, RK Pharma acquired life science company Vgyaan Pharmaceuticals

Acquisition Highlights
  • This is RK Pharma’s 1st transaction in the Life Science sector.
  • This is RK Pharma’s 1st transaction in the United States.
  • This is RK Pharma’s 1st transaction in New Jersey.

M&A Deal Summary
Date 2023-06-15
Target Vgyaan Pharmaceuticals
Sector Life Science
Buyer(s) RK Pharma
Deal Type Add-on Acquisition
Advisor(s) Blank Rome (Legal)

Target

Vgyaan Pharmaceuticals

Skillman, New Jersey, United States
Vgyaan Pharmaceuticals is focused on developing and commercializing clinically critical therapies across a variety of dosage forms and therapeutic categories. Vgyaan Pharmaceuticals is based in Skillman, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

RK Pharma

Pearl River, New York, United States
Category Company
Founded 2018
Sector Life Science
DESCRIPTION

RK Pharma is a fully integrated generic pharmaceutical company that develops complex API and injectable finished dosage products. RK Pharma was founded in 2018 and is based in Pearl River, New York.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: New Jersey M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal